Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GHRS · against 456 other Healthcare companies of similar size
Ranked #326 of 457 · scores higher than 9% of peers
Bars: peers in each 10-point band of the valuation score132 peers with a valuation score of 0–9, including GHRS · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | GHRS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 446 reported | -4.9% | 1.5% | 25% | 30% | |
| EBITDA yieldHigher is better · 460 reported | -6.9% | 4.5% | 17% | 50% | |
| Free cash flow yieldHigher is better · 209 reported | -3.7% | -0.8% | 38% | 20% | |
| Book yieldHigher is better · 451 reported | 25.8% | 40.4% | 32% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 326 | 1.4B USD | 8 | ||
| 326 | 1.3B USD | 8 | 30 | |
| 326 | 1.8B USD | 8 | 31 | |
| 326 | 1.6B USD | 8 | ||
| 326 | 1.4B USD | 8 | 38 | |
| 326 | 888M USD | 8 | 25 | |
| 326 | 1.5B USD | 8 | 44 | |
| 326 | 1.1B USD | 8 | 32 | |
| 326 | 2.4B USD | 8 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score